MS HB1265

Authorizes pharmacists to test, screen for, and treat minor, nonchronic health conditions including influenza, streptococcus, lice, skin conditions, and minor uncomplicated infections after completing an approved education course and meeting specified requirements.

Requires pharmacists to hold an active pharmacy license, complete an appropriate education course approved by the State Board of Pharmacy, maintain at least $250,000 in liability coverage, and maintain patient records for five years.

Mandates that pharmacists testing for and treating influenza or streptococcus operate under an established written protocol with a supervising practitioner approved by the State Board of Pharmacy, including specific patient categories, treatment instructions, and review processes.

Requires the State Board of Pharmacy to adopt a formulary within 180 days identifying medicinal drugs pharmacists may prescribe for approved conditions, excluding controlled substances but including FDA-approved over-the-counter medications.

Mandates that pharmacists providing these services complete annual continuing education courses approved by the board addressing minor, nonchronic health conditions in addition to existing licensure renewal requirements, effective July 1, 2020.